NORWOOD, MA--(Marketwire - April 01, 2008) - Apogee Technology, Inc. (OTCBB: ATCS) (the “Company”), which is developing PyraDerm™, a proprietary intradermal drug delivery system for vaccines and other pharmaceuticals, and IntellaPAL™, a proprietary sensor-based health monitoring system for the elderly care market, reported its financial results for the fiscal year ended December 31, 2007.
